“…The present study was not designed to measure the specific impact of aprotinin use in lung transplant patients, but its identification as an independent predictor of ARF serves to heighten the concerns about its safety in cohorts other than cardiac revascularization surgery. In accordance with other risk factors for ARF published in the literature, the present study also considered patient gender, the diagnosis of pre-operative arterial hypertension, the diagnosis of idiopathic pulmonary hypertension, the prolonged length of stay in the intensive care unit, the use of antibiotics, the use of radiographic contrast dye, the use of the cardiopulmonary bypass, and the use of calcineurin inhibitors in the immediate post-operative period, among others, as potential risk factors [21,22]. Of these factors, some were included in the multivariate model, while others were denied.…”